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Conclusions: Deletion of JNK2 retarded the development of exper-
imental murine OA, showing the importance of the kinase for cartilage
homeostasis in vivo and implicating an intracellular signalling pathway
in OA for the ﬁrst time.
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Purpose: We aimed to understand the mechanism by which mem-
brane-type 1 matrix metalloproteinase (MT1-MMP, MMP-14) controls
bone and cartilage homeostasis. MT1-MMP, a cell-membrane-bound
proteinase with an extracellular catalytic site and a 20-amino acid
cytoplasmic tail, degrades the extracellular matrix and plays a key role
in postnatal bone formation. MT1-MMP is overexpressed in osteo-
arthritis, and mutation of MT1-MMP in humans causes the multicentric
osteolysis and arthritis disease, Winchester syndrome. The genetic
deﬁciency of MT1-MMP (MT1-MMP-/-) in the mouse causes dwarﬁsm,
osteopenia and severe arthritis. Conditional deletion of MT1-MMP in
bone marrow-derived mesenchymal progenitor cells (BM-MSC) fully
recapitulates this phenotype, showing that MT1-MMP controls osteo-
genic differentiation inMSC. It has been proposed that the phenotype of
MT1-MMP-/- mice results from the lack of MT1-MMP proteolytic
activity. However, mounting evidence shows a variety of proteolysis-
independent functions of MT1-MMP. The unique tyrosine (Y573) in the
MT1-MMP cytoplasmic tail is fundamental for the control of intra-
cellular signaling. We have shown that Y573 mediates Ras-ERK1/2
signaling, and that Y573 mutation (Y573D) blocks this functionwithout
affecting MT1-MMP proteolytic activity.
Methods: We generated a mouse with the Y573D mutation in MT1-
MMP (MT1-MMP Y573D) and characterized its skeletal phenotype by
histological and microCT analyses. We isolated BM-MSC and induced
them to differentiate into osteoblasts, chondrocytes and adipocytes,
using qRT-PCR to analyze gene expression. Mouse C3H10T1/2MSCwere
transfected with MT1-MMP cDNA and analyzed for Wnt signaling and
Runx2 activation by luciferase reporter assays.
Results: Analysis of the long bones of both homozygote and heterozygote
MT1-MMP Y573D mice showed increased trabecular bone relative to wt
littermates (BV/TV %; - wt: 10 4±8; homo: 23.2±2.0; Tb.Th (mm) - wt:
20.5±3.8; homo: 40.1±7.0; Tb.N./mm - wt: 10.5±4.2; homo: 19.5 4.2;
Tb.Sp (mm): 325.2±52.1; 190.6 49.1; p0.01), a phenotypeopposite to that
of MT1-MMP-/- mice. MT1-MMP Y573D mice also showed marked thin-
ning of articular cartilage, with disorganized tissue architecture, cluster-
ing and cloning of chondrocytes, as well as pronounced decrease in bone
marrow-associated and total body fat (fat weight/body weight - wt:
0.270±0.0105; homo: 0.0135±0.006; p¼0.0029). These ﬁndings indicated
a defect in MSC differentiation. Therefore, we isolated BM-MSC from wt
and homozygous mutant littermates, and induced them to differentiate
into osteoblast and chondrocytes, and myeloid precursors were induced
to differentiate into osteoclasts. The Y573D mutation dramatically
increased MSC expression of osteoblast markers (ALP, COL1, BSP, OCN,
RUNX2) and strongly downregulated chondrocyte (ADA4, ADA5, SOX9,
MMP13) and osteoclast markers (TRACP, CALCR, CTSK, DC-STAMP, MMP9,
iNOS). These ﬁndings indicated thatWnt signaling is upregulated inMT1-
MMP Y573D-expressing MSC. The canonical Wnt pathway is indeed
unique, as it exerts opposite effects on osteoblast and chondrocyte dif-
ferentiation fromMSC. Therefore, we analyzedWnt signaling and Runx2
activation. We transiently transfected C3H10T1/2 MSC cells in osteoblast
medium with the cDNAs for wt MT1-MMP and MT1-MMP Y573D. As
controls the cellswere transfectedwith the empty vector (pcDNA) orwith
MT1-MMP E240A, a mutant devoid of proteolytic activity. MT1-MMPY573D dramatically upregulated both Wnt signaling (2.8-4.6-fold;
p¼0.007) and Runx2 activity (8.7-46.5-fold; ¼0.009) relative to wt MT1-
MMP and MT1-MMP E240A.
Conclusions: MT1-MMP controls Wnt signaling by a mechanism
independent of extracellular proteolysis and mediated by its cytoplas-
mic tail. MT1-MMP is a bifunctional protein, with an extracellular
proteolytic activity that promotes bone formation through ECM
remodeling and a cytoplasmic tail that controls osteogenesis by inter-
acting with a key pro-osteogenic signaling pathway.
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Purpose: The role of the NOTCH signaling pathway in articular cartilage
maintenance and osteoarthritis (OA) is controversial. Using conditional
NOTCH loss-of-function murine genetic models, we recently identiﬁed
the NOTCH signaling pathway as a critical regulator of joint cartilage
maintenance, while others have identiﬁed an increase in the expression
and activation of NOTCH signaling components in post-traumatic
murine and human OA. Therefore, we set out to determine whether
NOTCH signaling promotes joint cartilage maintenance, contributes to
the pathogenesis of OA, or potentially both depending on the strength
and/or duration of the signal.
Methods: To solve this questionwe developed two novel genetic mouse
models that allowed for either sustained NOTCH activation that likely
resembles pathological NOTCH signaling or transient NOTCH activation
that may more closely reﬂect physiological NOTCH signaling in joint
tissues. In vivo changes to joint and cartilage structure and gene
expression was monitored using histology, histomorphometry, real-
time qPCR, and immunohistochemistry (IHC). Furthermore, we devel-
oped an in vitro NOTCH gain-of-function primary chondrocyte culture
model, which mimicked our in vivo sustained NOTCH activation mouse
model, and performed large scale RNA-sequencing (RNAseq) to identify
direct and indirect targets of NOTCH signaling in cartilage. Numerous
targets were subsequently validated via in vitro models (primary
chondrocytes and ATDC5 cells), as well as, NOTCH-induced and post-
traumatic murine OA models using real-time qPCR, Western analysis,
and IHC.
Results: Our data demonstrate for the ﬁrst time that sustained versus
transient NOTCH activation in postnatal murine joint cartilages leads to
opposing effects on articular cartilage and joint maintenance. This study
establishes that sustained NOTCH activation in adult joint cartilage
results in a severe, early, and progressive OA-like pathology, while
transient NOTCH activation results in increased cartilage extracellular
matrix synthesis and joint maintenance under physiological conditions.
In vitro and in vivo studies demonstrate the capability of NOTCH sig-
naling to regulate both anabolic (Sox9, Col2a1, Acan, etc/) and catab-
olic gene expression (Mmp13, Adamts4, Adamts5, etc/), and RNAseq
experiments determined that sustained NOTCH activation suppresses
chondrogenic genes but promotes the expression of cartilage-related
proteases, ﬁbrotic collagens, and inﬂammatory factors including Il6.
Utilizing both in vivo and in vitro sustained NOTCH activation models
we demonstrate that the NOTCH-mediated suppression of chondro-
genic regulators, as well as, the activation of ﬁbrotic and catabolic fac-
tors may at least be partially mediated via NOTCH/IL6/ERK and NOTCH/
IL6/STAT3 signaling mechanisms, respectively. Furthermore, we show
that many of the NOTCH-induced signals leading to joint degeneration
are similarly affected in a post-traumatic OA mouse model.
Conclusions: Collectively, our data indicate that NOTCH signaling is a
critical pathway that regulates joint cartilage homeostasis and in
pathological situations of sustained signaling is involved in joint carti-
lage degradation, ﬁbrosis, and chondrogenic gene suppression. There-
fore, an appropriate balance of NOTCH signaling must be achieved
throughout life and following joint injury in order to maintain articular
cartilage homeostasis and joint integrity.
